N. D. Mola, E. Bellasio, P. Ferrari
Dec 1, 1985
Citations
0
Influential Citations
2
Citations
Journal
Journal of Labelled Compounds and Radiopharmaceuticals
Abstract
N-(2, 5-[2-13C]dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride ([2-13C]methyl MDL-899), a new antihypertensive agent, was synthesized for metabolic studies, in five steps via 2, 5-[1-13C]hexanedione, and characterized by 1H- and 13C-NMR, IR, and MS.